NEWARK, N.J., Jan. 5, 2021 /PRNewswire/ — NuggMD, the nation’s leading medical cannabis telemedicine service announced today that it is expanding its service to New Jersey patients, which will be the eighth state the company serves. The news comes as the company reaches an impressive milestone — over 650,000 medical cannabis cards have been issued to patients by licensed doctors through its platform.
On Aug. 11, 2020, the NJ Division of Consumer Affairs announced that medical marijuana patients would be allowed to receive their evaluation via telemedicine for the duration of the COVID 19 public health emergency. NuggMD will provide video-enabled telemedicine evaluations with fully-licensed New Jersey medical marijuana doctors for just $149. Yearly required follow-up visits will only cost $99. Evaluations are free of charge for patients who don’t qualify for New Jersey’s medical marijuana program.
“We welcome this decisive action by the Division and Governor Murphy,” says Alex Milligan, NuggMD Co-Founder and CMO. “Medical marijuna patients are often the most vulnerable to illness, and many are struggling to obtain essential services while effectively self-isolating during this pandemic.”
“We hope that the state continues this policy even after the pandemic is over,” says Kam Babazade, NuggMD Co-Founder and COO. “Telemedicine evaluations are an incredibly helpful tool for patients with compromised immune systems or mobility issues. It’s time for us to fully embrace the opportunities that telemedicine affords us. This is a huge public health advantage for the most vulnerable patients in our community.“
New Jersey hasn’t determined an end date for the state of emergency yet. There has been a resurgence of COVID-19 in several states, including the Garden State, which have led to increased social distancing measures and restrictions.
Since 2016, NuggMD has provided patients with a safe, convenient and affordable way to obtain a medical marijuana card. Their